Clinical trial
Predictive Value of miR-21 and miR-486 Expression in Patients Undergoing Clock-Guided Minimally Invasive Surgery for Pulmonary Nodules
NCT07060287 is registered in ClinicalTrials.gov with The First Hospital of Hebei Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Value of miR-21 and miR-486 Expression in Patients Undergoing Clock-Guided Minimally Invasive Surgery for Pulmonary Nodules
- Lead sponsor
- The First Hospital of Hebei Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- January 1, 2022
- Enrollment
- 138 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary nodule cm